Overcoming resistance in HER2-positive gastric cancer: a case report on the synergistic effect of pembrolizumab and trastuzumab
The observed synergy between pembrolizumab and trastuzumab highlights a promising treatment avenue that warrants further investigation.
Authors
- Qing Ma (ORCID: https://orcid.org/0000-0002-8361-5275)
- Diansheng Zhong (ORCID: https://orcid.org/0000-0001-6483-8134)
- Hui Lv (ORCID: https://orcid.org/0000-0002-0252-6706)
- Liyan Gu (ORCID: https://orcid.org/0000-0002-4609-3578)
- Yaoyao Ren (ORCID: https://orcid.org/0000-0001-8273-6895)
- Ting Gong (ORCID: https://orcid.org/0000-0001-7168-9851)
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1097/ms9.0000000000002614
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.42